Search results
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 2 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
There’s a new dominant COVID variant — but are the symptoms any different?
The Hill· 4 days agoThe latest projections from the Centers for Disease Control and Prevention show KP.3, a sublineage...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
The Sacramento Bee· 5 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID ...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Morningstar· 5 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID ...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Digital Journal· 5 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID ...
Thousands of Taylor Swift concertgoers in Madrid have come down with COVID-19 after Eras Tour
Salon via Yahoo News· 5 days agoIn the United States, scientists are warning of what they have been calling a "summer wave" of...
Household study suggests infants may spread C difficile
Center for Infectious Disease Research and Policy· 2 days agoA longitudinal household study found shared C difficile strains in 17 of 28 families, with the...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 5 days agoParticipants in the younger group got either the new vaccine or Spikevax and a standard-dose flu...
2-in-1 shot for flu and COVID shows promise in advanced trial
LiveScience· 5 days agoAn experimental two-in-one vaccine triggered strong immune responses against both the flu and SARS-CoV-2, the virus behind COVID-19, ...
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 2 days agoThe latest efficacy data align with the immunogenicity results, indicating that mRNA-1283 elicits...